BACKGROUND: Bioactive compounds from plants (i.e., Serenoa repens) are often used in medicine in the treatment of several pathologies, among which benign prostatic hyperplasia (BPH) associated to lower urinary tract symptoms (LUTS). DISCUSSION:There are different techniques of extraction, also used in combination, with the aim of enhancing the amount of the target molecules, gaining time and reducing waste of solvents. However, the qualitative and quantitative composition of the bioactives depends on the extractive process, and so the brands of the recovered products from the same plant are different in terms of clinical efficacy (no product interchangeability among different commercial brands). SUMMARY: In this review, we report on several...
Parts I and II of this three-part series indicated how a global review of both English-language and ...
Objective: Men affected with Benign Prostate Hyperplasia (BPH) and Lower Urinary Tract Symptoms (LUT...
To determine, by analysing all available clinical trial data, the clinical efficacy against placebo ...
Context: Herbal medicines are complex mixtures of various compounds. Standardisation is essential to...
BACKGROUND: The extract of Serenoa repens is the phytopharmaceutical product most often used for th...
We are experiencing a revival of interest in phytotherapeutic agents, both in Europe and North Ameri...
Background: Serenoa repens extract is the phytotherapeutic agent most frequently used for the treatm...
Objectives. Benign Prostatic Hyperplasia (BPH) is a form of benign tumor that occurs in humans mainl...
Part I of this 3-part series provided the groundwork for understanding the role of a standardized li...
Men affected with Benign Prostate Hyperplasia (BPH) and Lower Urinary Tract Symptoms (LUTS) are demo...
Objectives To comprehensively evaluate the efficacy and safety of the hexanic extract of Serenoa rep...
Phytotherapy remains one of the most popular methods of treating the initial stages of benign prosta...
Lower urinary tract symptoms (LUTS) are classically characterized as being related to storage (e.g.,...
To comprehensively evaluate the efficacy and safety of the hexanic extract of Serenoa repens (HESr, ...
Objectives. Benign Prostatic Hyperplasia (BPH) is a form of benign tumor that occurs in humans mainl...
Parts I and II of this three-part series indicated how a global review of both English-language and ...
Objective: Men affected with Benign Prostate Hyperplasia (BPH) and Lower Urinary Tract Symptoms (LUT...
To determine, by analysing all available clinical trial data, the clinical efficacy against placebo ...
Context: Herbal medicines are complex mixtures of various compounds. Standardisation is essential to...
BACKGROUND: The extract of Serenoa repens is the phytopharmaceutical product most often used for th...
We are experiencing a revival of interest in phytotherapeutic agents, both in Europe and North Ameri...
Background: Serenoa repens extract is the phytotherapeutic agent most frequently used for the treatm...
Objectives. Benign Prostatic Hyperplasia (BPH) is a form of benign tumor that occurs in humans mainl...
Part I of this 3-part series provided the groundwork for understanding the role of a standardized li...
Men affected with Benign Prostate Hyperplasia (BPH) and Lower Urinary Tract Symptoms (LUTS) are demo...
Objectives To comprehensively evaluate the efficacy and safety of the hexanic extract of Serenoa rep...
Phytotherapy remains one of the most popular methods of treating the initial stages of benign prosta...
Lower urinary tract symptoms (LUTS) are classically characterized as being related to storage (e.g.,...
To comprehensively evaluate the efficacy and safety of the hexanic extract of Serenoa repens (HESr, ...
Objectives. Benign Prostatic Hyperplasia (BPH) is a form of benign tumor that occurs in humans mainl...
Parts I and II of this three-part series indicated how a global review of both English-language and ...
Objective: Men affected with Benign Prostate Hyperplasia (BPH) and Lower Urinary Tract Symptoms (LUT...
To determine, by analysing all available clinical trial data, the clinical efficacy against placebo ...